Add time:07/22/2019         Source:sciencedirect.com

Niridazole, a nitro heterocyclic antischistosomal drug, is extensively metabolized to unknown metabolites by Schistosoma mansoni. We report that 1-thiocarbamoyl-2-imidazolidinone was isolated by high pressure liquid chromatography and identified by high resolution electron impact mass spectroscopy as a niridazole metabolite in schistosomes. After a 20-h in vitro incubation in 30 ml of medium containing 10 μg ml−1 [14C]niridazole (5.2 Ci mol−1), 100 S. mansoni worm pairs contained approximately 275 ng of 1-thiocarbamoyl-2-imidazolidinone. This amount represented 4% of the total metabolized fraction of niridazole in the parasite. Incubation of schistosomes with 1-thiocarbamoyl-2-[2 14C]imidazolidinone (2.7 Ci mol−1) indicated that this metabolite was not taken up. However, schistosomes released an average of 44 ng ml−1 or 1% of the total 1-thiocarbamoyl-2-imidazolidinone found in the worm back into 1 ml of medium during incubation. No host oxidative metabolites of niridazole were found in the parasites.

We also recommend Trading Suppliers and Manufacturers of 2-Imidazolidinone,1-(1-hydroxyethyl)-(9CI) (cas 109674-15-9). Pls Click Website Link as below: cas 109674-15-9 suppliers